Yahoo Web Search

Search results

1. • 

     Those who invested in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago are up 94%

     Simply Wall St. via Yahoo Finance· 2 years ago

     Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shareholders have seen the share price descend 22% over...

2. • 

     Alnylam Pharmaceuticals Inc (ALNY) Reports Strong Growth in 2023, Aiming for Continued Success ...

     GuruFocus.com via Yahoo Finance· 3 months ago

     Revenue Growth: Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) reported a 39% increase in annual global...

3. • 

     Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2023 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 1 year ago

     Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2023 Earnings Call Transcript May 4, 2023 Alnylam...

4. • 

     Why Alnylam Pharmaceuticals Topped the Market Today

     Motley Fool· 10 months ago

     What happened The fight against Alzheimer's disease seems to be advancing, and one biotech developing a treatment for the degenerative brain disorder...

5. • 

     Alnylam's (ALNY) Earnings and Revenues Lag Estimates in Q2

     Zacks via Yahoo Finance· 2 years ago

     Alnylam Pharmaceuticals, Inc. ALNY incurred a loss of $2.29 per share in the second quarter of 2022,...

6. • 

     The Zacks Analyst Blog Highlights ConocoPhillips SAP, CSX, Alnylam Pharmaceuticals and NVR

     Zacks via Yahoo Finance· 2 years ago

     For Immediate Release Chicago, IL – July 7, 2022 – Zacks.com announces the list of stocks featured...

7. • 

     Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback

     Zacks via Yahoo Finance· 7 months ago

     It was a busy week for the biotech sector. M&A is back in the spotlight in the sector as Bristol...

8. • 

     The Zacks Analyst Blog Highlights Microsoft, Salesforce, United Parcel Service, UnitedHealth and...

     Zacks via Yahoo Finance· 10 months ago

     For Immediate Release Chicago, IL – July 20, 2023 – Zacks.com announces the list of stocks featured...

9. • 

     10 clinical trials to watch in the first half of 2024

     BioPharma Dive via Yahoo Finance· 4 months ago

     Two years into a drawn-out downturn, the biotechnology sector finally got news that might buoy its...

10. • 

      Alnylam Is Now 'One Of The Most Binary' Stories In Biotech. Why The FDA Rejected Its Heart Drug.

      Investor's Business Daily· 7 months ago

      Alnylam stock skidded Monday after the Food and Drug Administration rejected its drug, Onpattro, as...